Diamorphine - paediatric investigation plan

Diamorphine

Key facts

• Active substance:
  Diamorphine
• Therapeutic area:
  Other
• Decision number:
  P/67/2010
• PIP number:
  Diamorphine
• Pharmaceutical form(s):
  Powder for solution for injection
• Condition(s) / indication(s):
  Treatment-resistant heroin dependence
• Route(s) of administration:
  Intravenous use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  04/05/2010
• Compliance check done:
  No

Decision

P/67/2010: European Medicines Agency decision on the granting of a product specific waiver for diamorphine (EMEA-000749-PIP01-09)

Adopted Reference Number: EMA/264336/2010